Breakthrough in hunt for common cold cure

Common cold

Common cold

The scientists found they were able to block replication of several strains of the virus without human cells being affected.

Viruses typically "hijack" NMT from human cells to construct the capsid - or protein shell - to protect the virus genome.

In a paper published to Nature Chemistry, the team detailed its new molecule, which targets N-myristoyltransferase (NMT), a protein in human cells.

Much of the effort to cure the common cold is centered around targeting the genomes of the viruses that cause it.

Producing a traditional vaccine for the common cold has proved to be a futile exercise but researchers at Imperial College may have discovered a novel new way to target the common cold and prevent its ability to replicate.

Until now it has been virtually impossible to vaccinate against cold virus because the condition is made of up a large family of different strains.

"Even if the cold has taken hold, it still might help lessen the symptoms".

HP Envy and Elite PCs: Smallest convertible to widest curved all-in-one
HP rates this model for up to 12 hours and 45 minutes of usage, which we look forward to testing with the Laptop Mag Battery Test. HP Audio Stream has been baked in, too, allowing you to use the ENVY AiO's speakers as the Bluetooth output for your phone.

Team: Former Sen. Harry Reid undergoes cancer surgery
Reid underwent surgery in 2015 after he fell and injured his eye while exercising at his home in Henderson. He retired from the Senate in 2017 .

Denver Broncos RB De'Angelo Henderson avoids serious injury in auto crash
The 5-7, 208-pound running back rushed seven times for 13 yards and caught two passes for 36 yards and a touchdown in 2017. "He was taken to the hospital as a precaution and is at the team's facility preparing to participate in OTAs next week".

The drug is also hypothetically effective in dealing with polio and foot and mouth disease, which have similar viruses to the common cold.

Rather than attacking the virus itself, which comes in hundreds of versions, the treatment targets the human host. A newly tested molecule appears to offer real hope.

They're working on making a form of the drug that can be inhaled as a way to reduce any further risks or complications.

The research team included the labs of Professor Roberto Solari and Professor Seb Johnston at Imperial's National Heart & Lung Institute, Dr Aurelie Mousnier from Imperial and Queen's University Belfast, structural biologists at the University of York, and colleagues at the Pirbright Institute.

By inventing a novel way to combine the two, they created a molecule, codenamed IMP-1088, which is more than a hundred times more potent than previous molecules targeting the protein in humans.

Laboratory tests showed how an experimental drug stopped the rhinovirus - the predominant cause of the common cold - hijacking a human protein to build the protective shell, or "capsid". They found two compounds that seemed to work well together, so they combined them to make IMP-1088.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.